Onchocerciasis Completed Phase 2 Trials for Rifampicin (DB01045)

Also known as: Onchocerca volvulus infection / Onchocercosis

IndicationStatusPhase
DBCOND0009881 (Onchocerciasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00127504Clinical Trial of Rifampin and Azithromycin for the Treatment of River BlindnessTreatment